Marketing-authorisation holder
Pal Pak
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMINOPHYLLINE100mg | 200mg · Tablet | Aminophylline | United States | Not marketed | 1975 |
| RAUVAL100mg | 50mg · Tablet | Rauwolfia serpentina root | United States | Not marketed | |
| TRIPLE SULFOID167mg; 167mg; 167mg · Tablet | Trisulfapyrimidines (sulfadiazine, Sulfamerazine, Sulfamethazine | United States | Not marketed | 1975 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 3 | 3 | 0 | CompaniesAll medicines |
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 1
- Roles
- Authorisation holder
Work with Prognia
Keep Pal Pak’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a call